Skip to main content
SpringerLink
Log in

β2-adrenergic receptor agonists/corticosteroid/montelukast

Treatment failure: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Eldaabossi SAM, et al. Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital. Respiratory Medicine Case Reports 34: 1 Oct 2021. Available from: URL: http://doi.org/10.1016/j.rmcr.2021.101520

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

β2-adrenergic receptor agonists/corticosteroid/montelukast. Reactions Weekly 1906, 14 (2022). https://doi.org/10.1007/s40278-022-14904-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-14904-9

Search

Navigation